Aberrant cytokeratin expression as a possible prognostic predictor in poorly differentiated colorectal carcinoma.

scientific article published in December 2013

Aberrant cytokeratin expression as a possible prognostic predictor in poorly differentiated colorectal carcinoma. is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1111/JGH.12319
P8608Fatcat IDrelease_aeilnaysrjfilmmks4km644pyy
P698PubMed publication ID23808938

P50authorYasuo ImaiQ79182549
P2093author name stringYoshihiko Ueda
Tohru Inoue
Hidetsugu Yamagishi
Yuko Ono
Takuya Okamura
Shinichi Ban
Kazunori Fukuda
P2860cites workThe human gene encoding cytokeratin 20 and its expression during fetal development and in gastrointestinal carcinomasQ24312239
Loss of CDX1 expression in colorectal carcinoma: promoter methylation, mutation, and loss of heterozygosity analyses of 37 cell linesQ24597859
Revised Bethesda Guidelines for hereditary nonpolyposis colorectal cancer (Lynch syndrome) and microsatellite instabilityQ24618618
Gastrointestinal differentiation marker Cytokeratin 20 is regulated by homeobox gene CDX1Q24651576
CpG island methylator phenotype in colorectal cancerQ24672170
The catalog of human cytokeratins: patterns of expression in normal epithelia, tumors and cultured cellsQ28262541
Molecular cloning, sequencing and expression of the mRNA encoding human Cdx1 and Cdx2 homeobox. Down-regulation of Cdx1 and Cdx2 mRNA expression during colorectal carcinogenesisQ28303785
CpG island methylator phenotype underlies sporadic microsatellite instability and is tightly associated with BRAF mutation in colorectal cancerQ29614277
Cdx1 promotes differentiation in a rat intestinal epithelial cell line.Q33882050
DNA methylation down-regulates CDX1 gene expression in colorectal cancer cell linesQ34139601
Differential diagnostic and functional role of the multi-marker phenotype CDX2/CK20/CK7 in colorectal cancer stratified by mismatch repair status.Q34790095
Diagnostic strategies for unknown primary cancerQ35757876
Selecting immunohistochemical cut-off scores for novel biomarkers of progression and survival in colorectal cancerQ36054860
Differential mucin phenotypes and their significance in a variation of colorectal carcinomaQ36987832
Expression of cytokeratins 7 and 20 in primary carcinomas of the stomach and colorectum and their value in the differential diagnosis of metastatic carcinomas to the ovaryQ44231588
Cytokeratin 7 and cytokeratin 20 expression in epithelial neoplasms: a survey of 435 casesQ46145645
Reduced expression of cytokeratin 20 in colorectal carcinomas with high levels of microsatellite instabilityQ47420591
CDX1 expression is reduced in colorectal carcinoma and is associated with promoter hypermethylation.Q54700906
P433issue12
P304page(s)1815-1822
P577publication date2013-12-01
P1433published inJournal of Gastroenterology and HepatologyQ15764401
P1476titleAberrant cytokeratin expression as a possible prognostic predictor in poorly differentiated colorectal carcinoma
P478volume28

Reverse relations

cites work (P2860)
Q51648276A Critical Evaluation of the PAXgene Tissue Fixation System:  Morphology, Immunohistochemistry, Molecular Biology, and Proteomics.
Q40978030Altered expression of cytokeratin 7 and CD117 in transitional mucosa adjacent to human colorectal cancer
Q48257136Collision tumor consisting of a colorectal adenocarcinoma and dissemination of a gastric adenocarcinoma
Q51075590Poorly differentiated adenocarcinoma of the colon: subsite location and clinicopathologic features.
Q55223758SATB2 Shows Different Profiles Between Appendiceal Adenocarcinomas Ex Goblet Cell Carcinoids and Appendiceal/Colorectal Conventional Adenocarcinomas: An Immunohistochemical Study With Comparison to CDX2.